[ad_1]
SINGAPORE – Regulatory flaws found at Concord International Hospital (CIH) were not linked to the management of any Covid-19 cases, the Ministry of Health (MOH) said on Sunday (December 27).
This is based on their inspection so far, said a spokesman for the Health Ministry.
The private hospital, which specializes in cancer treatment, was hired by the Ministry of Health to help care for Covid-19 patients who were clinically well but tested positive for the virus, and did so from March to September.
On Saturday, the Health Ministry announced that it had temporarily prevented the hospital from providing all health care services since December 19, after several major violations of the Private Hospitals and Medical Clinics Act (PHMC) were found during inspections. ). These lapses affected patient safety.
“Various equipment and life-saving drugs were not maintained or were not available in critical areas of the hospital such as the intensive care unit and the operating room,” the Health Ministry said on Saturday.
“There was also a lack of quality control in the laboratory and infection control processes, posing significant risks to patient safety and well-being.”
There were no patients in custody at Adam Road Hospital. A 2018 report said it has 31 beds.
The Ministry of Health has informed CIH to work with its medical team to review treatment plans and ensure adequate continuity of outpatient care for the four patients who had ongoing outpatient medical appointments as of December 19, while the hospital addresses their lapses.
The hospital could not be reached for comment.
Last Wednesday, after its operations were halted, CIH said in a Facebook post that it welcomed the arrival of a new administration in late November.
“With input from the Ministry of Health in view of the ownership change, the administration has decided to take the opportunity to renovate the hospital, improve our protocols and introduce new services to better meet the needs of patients in the future,” he said.
He added that the hospital will be relaunched at the end of January 2021 “with new specialties and unique treatments,” and with a new name.
[ad_2]
